Review
doi: 10.1016/s0074-7742(08)60039-2.
Neurochemical and neuropharmacological aspects of depression
- PMID: 1354
- DOI: 10.1016/s0074-7742(08)60039-2
Item in Clipboard
Review
Neurochemical and neuropharmacological aspects of depression
Int Rev Neurobiol.
1975.
No abstract available
Similar articles
-
Theories of biological etiology of affective disorders.Int Rev Neurobiol. 1970;12:145-75. doi: 10.1016/s0074-7742(08)60060-4. Int Rev Neurobiol. 1970. PMID: 4918142 Review. No abstract available.
-
Practical clinical psychopharmacology: the antidepressants and lithium.J Indiana State Med Assoc. 1975 Nov;68(11):953-5. J Indiana State Med Assoc. 1975. PMID: 1184994 No abstract available.
-
Tryptophan in the treatment of depression.Adv Exp Med Biol. 1981;133:727-37. doi: 10.1007/978-1-4684-3860-4_40. Adv Exp Med Biol. 1981. PMID: 6459010 No abstract available.
-
[The role of serotonin in affective disorders (author's transl)].Encephale. 1979;5(5 Suppl):499-506. Encephale. 1979. PMID: 95007 French. No abstract available.
-
[Biochemistry of depression. Literature analysis].Encephale. 1978;4(3):193-222. Encephale. 1978. PMID: 30616 Review. French.
Cited by
-
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):857-73. doi: 10.1007/s10571-006-9012-5. Epub 2006 Apr 25. Cell Mol Neurobiol. 2006. PMID: 16636898 Free PMC article.
-
Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.Psychopharmacology (Berl). 1977 Aug 16;53(3):309-14. doi: 10.1007/BF00492370. Psychopharmacology (Berl). 1977. PMID: 408861